# Aneuploidy alleviates the cell proliferation defect caused by mutations affecting origin licensing in Saccharomyces cerevisiae

**Authors:** Christophe de La Roche Saint-André

PMC · DOI: 10.1371/journal.pgen.1012063 · 2026-02-27

## TL;DR

Extra chromosomes can help yeast cells with DNA replication defects by extending a key cell cycle phase.

## Contribution

Aneuploidy compensates for DNA replication licensing defects by prolonging the G1 phase in yeast.

## Key findings

- An extra chromosome III copy improves growth in orc5–1 mutants.
- Growth enhancement is not gene-specific but depends on G1 phase extension.
- Cln3 deletion mimics the growth benefit of aneuploidy in replication mutants.

## Abstract

Although aneuploidy is generally detrimental to the survival and growth of normal cells, it can be beneficial under certain stress conditions, such as those caused by harmful mutations. In Saccharomyces cerevisiae, we find that duplication of chromosome III accelerates cell proliferation in the orc5–1 mutant. Enhanced proliferation is also observed when a fragment from a different chromosome is introduced, demonstrating that the benefit is not simply due to extra copies of specific genes. A comparable growth-enhancing effect of an extra chromosome is observed for mutations affecting other proteins involved in DNA replication licensing. The suppression of orc5–1 growth defect is also observed in the absence of the G1 cyclin Cln3, which lengthens the G1 phase, while overexpressing CLN3, which shortens G1, has the opposite effect. Additionally, Cln3 loss mirrors the effect of an extra chromosome for other mutations. These findings indicate that the severity of mutations impacting origin licensing hinges on the length of the G1 phase. Thus, we propose that the fitness-enhancing effect of an extra chromosome in DNA replication licensing mutants largely stems from its ability to extend G1, compensating for inefficient origin licensing.

While having the wrong number of chromosomes, known as aneuploidy, is usually detrimental to cells, it can sometimes promote survival under stressful conditions, such as those arising from certain genetic mutations. Using the yeast model Saccharomyces cerevisiae, we discovered that an extra copy of chromosome III enhances the growth of a mutant strain with defects in DNA replication licensing. This growth advantage does not rely on specific genes located on chromosome III, as a different chromosomal fragment confers a similar benefit. We also found that prolonging the G1 phase of the cell cycle, a common consequence of aneuploidy, by deleting the cell cycle regulator Cln3, similarly supports growth in these mutants. Our finding suggests that the fitness advantage provided by aneuploidy in replication licensing mutants primarily stems from the extended G1 phase, which gives additional time for the preparation of DNA replication when origin licensing is compromised.

## Linked entities

- **Genes:** Orc5 (origin recognition complex subunit 5) [NCBI Gene 108977143], CLN3 (CLN3 lysosomal/endosomal transmembrane protein, battenin) [NCBI Gene 1201], CLN3 (CLN3 lysosomal/endosomal transmembrane protein, battenin) [NCBI Gene 1201]
- **Species:** Saccharomyces cerevisiae (taxon 4932)

## Full-text entities

- **Genes:** MRC1 (chromatin-modulating protein MRC1) [NCBI Gene 850297] {aka YCL060C}, CHL1 (DNA helicase) [NCBI Gene 856099] {aka CTF1, LPA9, MCM12}, CDC15 (serine/threonine protein kinase CDC15) [NCBI Gene 851274] {aka LYT1, RLT1}, CLN3 (cyclin CLN3) [NCBI Gene 851191] {aka DAF1, FUN10, WHI1}, CDC28 (cyclin-dependent serine/threonine-protein kinase CDC28) [NCBI Gene 852457] {aka CDK1, HSL5, SRM5}, ALA1 (alanine--tRNA ligase) [NCBI Gene 854513] {aka CDC64}, MAD2 (spindle checkpoint protein MAD2) [NCBI Gene 853422], GAL1 (galactokinase) [NCBI Gene 852308], SET1 (histone methyltransferase SET1) [NCBI Gene 856519] {aka KMT2, YTX1}, RER1 (protein retrieval receptor) [NCBI Gene 850354], SMC3 (cohesin subunit SMC3) [NCBI Gene 853371], SIC1 (cyclin-dependent protein serine/threonine kinase inhibiting protein SIC1) [NCBI Gene 850768] {aka BYC1, SDB25}, CDC7 (serine/threonine protein kinase CDC7) [NCBI Gene 851545] {aka LSD6, SAS1}, TAH11 (Tah11p) [NCBI Gene 853504] {aka CDT1, SID2}, CDC6 (AAA family ATPase CDC6) [NCBI Gene 853244], URA3 (orotidine-5'-phosphate decarboxylase) [NCBI Gene 856692], MCM3 (MCM DNA helicase complex subunit MCM3) [NCBI Gene 856680], SCC2 (cohesin-loading factor complex subunit SCC2) [NCBI Gene 851761], DCC1 (Dcc1p) [NCBI Gene 850344], RAD52 (recombinase RAD52) [NCBI Gene 854976], ORC5 (origin recognition complex subunit 5) [NCBI Gene 855460], ORC2 (origin recognition complex subunit 2) [NCBI Gene 852352] {aka RRR1, SIR5}, CDC14 (phosphoprotein phosphatase CDC14) [NCBI Gene 850585] {aka OAF3}, SMC1 (cohesin subunit SMC1) [NCBI Gene 850540] {aka CHL10}, POL1 (DNA-directed DNA polymerase alpha catalytic subunit POL1) [NCBI Gene 855621] {aka CDC17, CRT5, HPR3}, MCM21 (Mcm21p) [NCBI Gene 851916] {aka CTF5}, ADE16 (bifunctional phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase ADE16) [NCBI Gene 850715], SUP11 (tRNA-Tyr) [NCBI Gene 850564]
- **Diseases:** III disomy (MESH:D024182), chromosomal abnormalities (MESH:D002869), cancer (MESH:D009369), Chromosome III disomy (MESH:C536470), WT (MESH:D009396), lethality (MESH:C536057), Aneuploidy (MESH:D000782), chromosome (MESH:D025063), SCC (MESH:D001816)
- **Chemicals:** potassium acetate (MESH:D019347), uracil (MESH:D014498), histidine (MESH:D006639), hygromycin B (MESH:D006921), nourseothricin (MESH:D013309), adenine (MESH:D000225), ethanol (MESH:D000431), galactose (MESH:D005690), SD medium (-), amino acids (MESH:D000596), ammonium sulfate (MESH:D000645), PBS (MESH:D007854), Sytox Green (MESH:C402795), tryptophan (MESH:D014364), glucose (MESH:D005947)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S11A, S10A, S13A, S11C
- **Cell lines:** YAC-2 — Mus musculus (Mouse), Mouse lymphoma, Cancer cell line (CVCL_2244), orc5-1 — Mus musculus (Mouse), Mouse lymphoma, Cancer cell line (CVCL_3839), pRS313 — Homo sapiens (Human), Xeroderma pigmentosum, complementation group F, Transformed cell line (CVCL_ZS42)

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965678/full.md

---
Source: https://tomesphere.com/paper/PMC12965678